Serum Osteocalcin is Associated with Measures of Insulin Resistance, Adipokine Levels, and the Presence of Metabolic Syndrome

Overview

Journal Arterioscler Thromb Vasc Biol

Date 2010 Apr 17

PMID 20395593

Citations 74

Authors

Umer Saleem

Thomas H Mosley Jr

Iftikhar J Kullo

Affiliations

Soon will be listed here.

Abstract

Objective: Osteocalcin has been reported to influence insulin secretion in experimental animals. We investigated whether serum osteocalcin was associated with measures of insulin resistance, circulating adipokine levels, and the presence of metabolic syndrome (MetSyn).

Methods And Results: Serum osteocalcin was measured by solid-phase sandwich immunoassay in 1284 blacks (64+/-9 years; 71% women) and 1209 non-Hispanic whites (59+/-10 years; 57% women) belonging to hypertensive sibships. MetSyn was defined per Adult Treatment Panel III criteria. The prevalence of MetSyn was 50% in blacks and 49% in non-Hispanic whites. In each ethnic group, after adjustment for age and gender, osteocalcin levels were inversely correlated with body mass index, fasting glucose and insulin, homeostasis model assessment of insulin resistance, triglycerides, and leptin, and positively correlated with adiponectin (P<0.001 for each variable). In multivariable regression analyses that adjusted for age, gender, smoking, serum creatinine, and statin and estrogen use, osteocalcin levels in the highest quartile (compared with the lowest quartile) were associated with a lower odds ratio (OR) of having MetSyn: OR (95% CI) in blacks, 0.33 (0.23 to 0.46); OR in non-Hispanic whites, 0.43 (0.31 to 0.63).

Conclusions: Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of MetSyn, suggesting a novel cross-talk between bone and adipose tissue.

Citing Articles

Ethnic differences in vitamin D status, bone and body composition in South Asian indian and caucasian men.

Altasan A, Aljahdali A, Ramadoss R, Cheung M, Dall R, Bruneau Jr M Metabol Open. 2024; 23:100302.

PMID: 39161755 PMC: 11331910. DOI: 10.1016/j.metop.2024.100302.

Ketosis Suppression and Ageing (KetoSAge) Part 2: The Effect of Suppressing Ketosis on Biomarkers Associated with Ageing, HOMA-IR, Leptin, Osteocalcin, and GLP-1, in Healthy Females.

Cooper I, Kyriakidou Y, Petagine L, Edwards K, Soto-Mota A, Brookler K Biomedicines. 2024; 12(7).

PMID: 39062126 PMC: 11274887. DOI: 10.3390/biomedicines12071553.

Extrahepatic Vitamin K-Dependent Gla-Proteins-Potential Cardiometabolic Biomarkers.

Galunska B, Yotov Y, Nikolova M, Angelov A Int J Mol Sci. 2024; 25(6).

PMID: 38542487 PMC: 10971439. DOI: 10.3390/ijms25063517.

Osteocalcin and Metabolic Syndrome.

Viswanath A, Vidyasagar S, Sukumar C Clin Med Insights Endocrinol Diabetes. 2023; 16:11795514231206729.

PMID: 37954481 PMC: 10634259. DOI: 10.1177/11795514231206729.

Updates in the chronic kidney disease-mineral bone disorder show the role of osteocytic proteins, a potential mechanism of the bone-Vascular paradox, a therapeutic target, and a biomarker.

Williams M, White S, Joseph Z, Hruska K Front Physiol. 2023; 14:1120308.

PMID: 36776982 PMC: 9909112. DOI: 10.3389/fphys.2023.1120308.

References

Pittas A, Harris S, Eliades M, Stark P, Dawson-Hughes B . Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab. 2008; 94(3):827-32. PMC: 2681283. DOI: 10.1210/jc.2008-1422. View

Richards J, Valdes A, Burling K, Perks U, Spector T . Serum adiponectin and bone mineral density in women. J Clin Endocrinol Metab. 2007; 92(4):1517-23. DOI: 10.1210/jc.2006-2097. View

Kawai M, Devlin M, Rosen C . Fat targets for skeletal health. Nat Rev Rheumatol. 2009; 5(7):365-72. PMC: 3661210. DOI: 10.1038/nrrheum.2009.102. View

Ducy P, Schinke T, Karsenty G . The osteoblast: a sophisticated fibroblast under central surveillance. Science. 2000; 289(5484):1501-4. DOI: 10.1126/science.289.5484.1501. View

Yokoyama H, Emoto M, Fujiwara S, Motoyama K, Morioka T, Komatsu M . Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose. J Clin Endocrinol Metab. 2004; 89(3):1481-4. DOI: 10.1210/jc.2003-031374. View

Ferron M, Hinoi E, Karsenty G, Ducy P . Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A. 2008; 105(13):5266-70. PMC: 2278202. DOI: 10.1073/pnas.0711119105. View

Lee N, Karsenty G . Reciprocal regulation of bone and energy metabolism. Trends Endocrinol Metab. 2008; 19(5):161-6. DOI: 10.1016/j.tem.2008.02.006. View

Lakka H, Laaksonen D, Lakka T, Niskanen L, Kumpusalo E, Tuomilehto J . The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002; 288(21):2709-16. DOI: 10.1001/jama.288.21.2709. View

. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19):2486-97. DOI: 10.1001/jama.285.19.2486. View

10.

Takeda S, Karsenty G . Molecular bases of the sympathetic regulation of bone mass. Bone. 2008; 42(5):837-40. DOI: 10.1016/j.bone.2008.01.005. View

11.

Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7):412-9. DOI: 10.1007/BF00280883. View

12.

Zhao L, Liu Y, Liu P, Hamilton J, Recker R, Deng H . Relationship of obesity with osteoporosis. J Clin Endocrinol Metab. 2007; 92(5):1640-6. PMC: 1868430. DOI: 10.1210/jc.2006-0572. View

13.

Rosato M, Schneider S, Shapses S . Bone turnover and insulin-like growth factor I levels increase after improved glycemic control in noninsulin-dependent diabetes mellitus. Calcif Tissue Int. 1998; 63(2):107-11. DOI: 10.1007/s002239900498. View

14.

Zeger S, Liang K . Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986; 42(1):121-30. View

15.

Kim C, Bailey K, Klee G, Ellington A, Liu G, Mosley Jr T . Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study. PLoS One. 2010; 5(2):e9065. PMC: 2816715. DOI: 10.1371/journal.pone.0009065. View

16.

Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, Yano S . Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2008; 94(1):45-9. DOI: 10.1210/jc.2008-1455. View

17.

Lee N, Sowa H, Hinoi E, Ferron M, Ahn J, Confavreux C . Endocrine regulation of energy metabolism by the skeleton. Cell. 2007; 130(3):456-69. PMC: 2013746. DOI: 10.1016/j.cell.2007.05.047. View

18.

Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, Kita S . Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature. 2003; 423(6941):762-9. DOI: 10.1038/nature01705. View

19.

. Multi-center genetic study of hypertension: The Family Blood Pressure Program (FBPP). Hypertension. 2002; 39(1):3-9. DOI: 10.1161/hy1201.100415. View

20.

Grundy S, Brewer Jr H, Cleeman J, Smith Jr S, Lenfant C . Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004; 109(3):433-8. DOI: 10.1161/01.CIR.0000111245.75752.C6. View